Andere Sprachen AstraZeneca Pharma India Limited NSE India S.E.

Aktien

A1JBJ2

INE203A01020

ASTRAZEN

Markt geschlossen - NSE India S.E. Andere Börsenplätze 13:43:51 31.05.2024			% 5 Tage	% 1. Jan.
6.179 ^INR	-2,85 %		+2,56 %	+11,81 %

27.05.	AstraZeneca Pharma India Limited gibt den Rucktritt von Ankush Nandra als Non-Executive Director bekannt	CI
27.05.	AstraZeneca Pharma India Limited berichtet über die Ergebnisse für das vierte Quartal bis zum 31. März 2024	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Astrazeneca Pharma India's Net Profit Rises in Fiscal Q4	28.05.
AstraZeneca Pharma India Limited Announces Resignation of Ankush Nandra as Non-Executive Director	27.05.
Astrazeneca Pharma India Limited Recommends Dividend for the Financial Year 2023-24	27.05.
AstraZeneca Pharma India Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	27.05.
AstraZeneca Pharma India Limited Reports Earnings Results for the Full Year Ended March 31, 2024	27.05.
Astrazeneca Pharma India Limited Provides Update on Olaparib 100mg and 150 mg Tablets	21.05.
AstraZeneca Pharma India Limited Approves Appointment of Bhavana Agrawal as Director and Whole Time Director	08.04.
AstraZeneca Pharma India Limited Appoints Vinay Sharma as Business Unit Head - Rare Disease, Effective July 1, 2024	25.03.
AstraZeneca, Mankind Pharma Tie Up for Exclusive Distribution of Asthma Drug Symbicort in India	11.03.
Astrazeneca Pharma India Ltd and Mankind Pharma Partner to Accelerate Access to Asthma Medicine for Patients in India	11.03.
Astrazeneca Pharma India Limited Announces Board Changes	20.02.
AstraZeneca Pharma India Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	08.02.
AstraZeneca Pharma India Limited Announces Board Changes	08.02.
AstraZeneca Pharma India Limited Announces Directorate Appointments	07.02.
AstraZeneca Gets Indian Drug Regulator's Nod to Import Andexanet Alfa Powder for Solution for Infusion	22.01.
Astrazeneca Pharma to Launch Breast Cancer Treatment Drug in India in January 2024	21.12.
India's Nifty set for muted open after steep drop	21.12.
Astrazeneca Pharma India Limited Appoints Hooi-Bien Chuah as Additional Director (Non-Executive)	09.11.
AstraZeneca Pharma India Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	09.11.
Astrazeneca Pharma India Limited Receives Permission to Import Pharmaceutical Formulations Of New Drug For Sale Or For Distribution In Form CT-20 From Central Drugs Standard Control Organisation For Palivizumab	30.09.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen AstraZeneca Pharma India Limited NSE India S.E.

Aktien

A1JBJ2

INE203A01020

ASTRAZEN

Andere Sprachen

Filter